Study summary · research use only
AOD-9604 Metabolic
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This brief note reports that the company Metabolic was developing AOD-9604 as a potential obesity treatment, and that by February 2002 phase IIa trials were underway. No study design, species, or outcomes are described.
Abstract
Metabolic is developing AOD-9604 for the potential treatment of obesity. By February 2002, phase IIa trials were underway.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.